Australia is facing a massive increase in the number of people who could unnecessarily lose their sight to wet age-related macular degeneration (AMD) due to treatment cancellations caused by fear and confusion around COVID-19.
In the last few weeks, the world has changed rapidly with the spread of the coronavirus known as COVID-19. This rapid change can create anxiety and uncertainty as we make the necessary changes in our daily lives to fight this unprecedented event.
MDFA awards $600,000 to researchers on World Sight Day
MDFA has awarded a further $600,000 to three leading researchers in a prestigious event held at Admiralty House, the Governor-General of Australia's residence in Sydney, on World Sight Day (10 October).
Proposed changes to Medicare for eye injections: what you need to know
The Medicare Benefits Schedule (MBS) Review Taskforce for Ophthalmology (The Taskforce) has developed a draft report suggesting changes to Medicare rebates for intravitreal injections (eye injections).
National Strategic Action Plan for Macular Disease
The National Strategic Action Plan for Macular Disease, outlining a national, coordinated response to macular disease, has been released with a federal government commitment of $3m over the next four years.